FindTrial
Sign In

Effect of using antihistamines in the treatment of chronic spontaneous urticaria

Comparison of efficacy of fexofenadine and levocetirizine in treatment of chronic spontaneous urticaria-A non blinded randomized control study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074989
Enrollment
100
Registered
2024-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

Intervention1: Levocetirizine: 5 mg once daily orally for 3 months Intervention2: Oral antihistamines: Comparison of fexofenadine 180 mg od and levocetirizine 5 mg OD daily for 3 months Control Interv

Sponsors

DR MOHANRAJ S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age above 12 years 2) Both sexes included 3)Patients with chronic idiopathic urticaria for more than 6 weeks 4) Patients willing to give consent for study and followup 5) Patients not on any other treatment for urticaria

Exclusion criteria

Exclusion criteria: 1)Patients with known causes of urticaria are excluded 2)Pregnant and lactating women 3)Patients with impaired renal function 4)Patients with all cardiac abnormalities 5)Patients not willing for regular followup

Design outcomes

Primary

MeasureTime frame
Reducing itch severity and wheals numberTimepoint: 6 months—

Secondary

MeasureTime frame
Complete clearance of itch and whealsTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Vijayabhaskar C

Government stanley medical college and hospital

buskibuski@gmail.com9940429206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026